Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 265 entries
Sorted by: Best Match Show Resources per page
Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control - the prospective COVAC-DM cohort study.

Diabetes, obesity & metabolism

Sourij C, Tripolt NJ, Aziz F, Aberer F, Forstner P, Obermayer AM, Kojzar H, Kleinhappl B, Pferschy PN, Mader JK, Cvirn G, Goswami N, Wachsmuth N, Eckstein ML, Müller A, Abbas F, Lenz J, Steinberger M, Knoll L, Krause R, Stradner M, Schlenke P, Sareban N, Prietl B, Kaser S, Moser O, Steinmetz I, Sourij H.
PMID: 34984802
Diabetes Obes Metab. 2022 Jan 04; doi: 10.1111/dom.14643. Epub 2022 Jan 04.

AIMS: Immune response to COVID-19 vaccination and a potential impact of glycaemia on antibody levels in people with diabetes remains unclear. We investigated the seroconversion following first and second COVID-19 vaccination in people with type 1 and type 2...

Cite
Sourij C, Tripolt NJ, Aziz F, et al. Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control - the prospective COVAC-DM cohort study. Diabetes Obes Metab. 2022;doi: 10.1111/dom.14643.
Sourij, C., Tripolt, N. J., Aziz, F., Aberer, F., Forstner, P., Obermayer, A. M., Kojzar, H., Kleinhappl, B., Pferschy, P. N., Mader, J. K., Cvirn, G., Goswami, N., Wachsmuth, N., Eckstein, M. L., Müller, A., Abbas, F., Lenz, J., Steinberger, M., Knoll, L., Krause, R., Stradner, M., Schlenke, P., Sareban, N., Prietl, B., Kaser, S., Moser, O., Steinmetz, I., Sourij, H. (2022). Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control - the prospective COVAC-DM cohort study. Diabetes, obesity & metabolism, . https://doi.org/10.1111/dom.14643
Sourij, Caren, et al. "Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control - the prospective COVAC-DM cohort study." Diabetes, obesity & metabolism vol. (2022). doi: https://doi.org/10.1111/dom.14643
Sourij C, Tripolt NJ, Aziz F, Aberer F, Forstner P, Obermayer AM, Kojzar H, Kleinhappl B, Pferschy PN, Mader JK, Cvirn G, Goswami N, Wachsmuth N, Eckstein ML, Müller A, Abbas F, Lenz J, Steinberger M, Knoll L, Krause R, Stradner M, Schlenke P, Sareban N, Prietl B, Kaser S, Moser O, Steinmetz I, Sourij H. Humoral immune response to Covid-19 vaccination in diabetes: age-dependent but independent of type of diabetes and glycaemic control - the prospective COVAC-DM cohort study. Diabetes Obes Metab. 2022 Jan 04; doi: 10.1111/dom.14643. Epub 2022 Jan 04. PMID: 34984802.
Copy Download .nbib Format: NLM
Ischemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full and half-dose Edoxaban vs. Warfarin: insights from ENGAGE AF-TIMI 48.

European heart journal. Cardiovascular pharmacotherapy

Bonaca MP, Antman EM, Cunningham JW, Wiviott SD, Murphy SA, Halperin JL, Weitz JI, Grosso MA, Lanz HJ, Braunwald E, Giugliano RP, Ruff CT.
PMID: 34962979
Eur Heart J Cardiovasc Pharmacother. 2021 Dec 28; doi: 10.1093/ehjcvp/pvab089. Epub 2021 Dec 28.

AIMS: In patients with atrial fibrillation (AF), peripheral artery disease (PAD) is associated with higher rates of stroke and bleeding. Both higher-dose edoxaban (60/30mg) and lower-dose edoxaban (30/15) were non-inferior to warfarin for stroke/systemic embolism (SEE) and significantly reduced...

Cite
Bonaca MP, Antman EM, Cunningham JW, et al. Ischemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full and half-dose Edoxaban vs. Warfarin: insights from ENGAGE AF-TIMI 48. Eur Heart J Cardiovasc Pharmacother. 2021;doi: 10.1093/ehjcvp/pvab089.
Bonaca, M. P., Antman, E. M., Cunningham, J. W., Wiviott, S. D., Murphy, S. A., Halperin, J. L., Weitz, J. I., Grosso, M. A., Lanz, H. J., Braunwald, E., Giugliano, R. P., & Ruff, C. T. (2021). Ischemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full and half-dose Edoxaban vs. Warfarin: insights from ENGAGE AF-TIMI 48. European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvab089
Bonaca, Marc P, et al. "Ischemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full and half-dose Edoxaban vs. Warfarin: insights from ENGAGE AF-TIMI 48." European heart journal. Cardiovascular pharmacotherapy vol. (2021). doi: https://doi.org/10.1093/ehjcvp/pvab089
Bonaca MP, Antman EM, Cunningham JW, Wiviott SD, Murphy SA, Halperin JL, Weitz JI, Grosso MA, Lanz HJ, Braunwald E, Giugliano RP, Ruff CT. Ischemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full and half-dose Edoxaban vs. Warfarin: insights from ENGAGE AF-TIMI 48. Eur Heart J Cardiovasc Pharmacother. 2021 Dec 28; doi: 10.1093/ehjcvp/pvab089. Epub 2021 Dec 28. PMID: 34962979.
Copy Download .nbib Format: NLM
Reprogramming CBX8-PRC1 function with a positive allosteric modulator.

Cell chemical biology

Suh JL, Bsteh D, Hart B, Si Y, Weaver TM, Pribitzer C, Lau R, Soni S, Ogana H, Rectenwald JM, Norris JL, Cholensky SH, Sagum C, Umana JD, Li D, Hardy B, Bedford MT, Mumenthaler SM, Lenz HJ, Kim YM, Wang GG, Pearce KH, James LI, Kireev DB, Musselman CA, Frye SV, Bell O.
PMID: 34715055
Cell Chem Biol. 2021 Oct 26; doi: 10.1016/j.chembiol.2021.10.003. Epub 2021 Oct 26.

Canonical targeting of Polycomb repressive complex 1 (PRC1) to repress developmental genes is mediated by cell-type-specific, paralogous chromobox (CBX) proteins (CBX2, 4, 6, 7, and 8). Based on their central role in silencing and their dysregulation associated with human...

Cite
Suh JL, Bsteh D, Hart B, et al. Reprogramming CBX8-PRC1 function with a positive allosteric modulator. Cell Chem Biol. 2021;doi: 10.1016/j.chembiol.2021.10.003.
Suh, J. L., Bsteh, D., Hart, B., Si, Y., Weaver, T. M., Pribitzer, C., Lau, R., Soni, S., Ogana, H., Rectenwald, J. M., Norris, J. L., Cholensky, S. H., Sagum, C., Umana, J. D., Li, D., Hardy, B., Bedford, M. T., Mumenthaler, S. M., Lenz, H. J., Kim, Y. M., Wang, G. G., Pearce, K. H., James, L. I., Kireev, D. B., Musselman, C. A., Frye, S. V., & Bell, O. (2021). Reprogramming CBX8-PRC1 function with a positive allosteric modulator. Cell chemical biology, . https://doi.org/10.1016/j.chembiol.2021.10.003
Suh, Junghyun L, et al. "Reprogramming CBX8-PRC1 function with a positive allosteric modulator." Cell chemical biology vol. (2021). doi: https://doi.org/10.1016/j.chembiol.2021.10.003
Suh JL, Bsteh D, Hart B, Si Y, Weaver TM, Pribitzer C, Lau R, Soni S, Ogana H, Rectenwald JM, Norris JL, Cholensky SH, Sagum C, Umana JD, Li D, Hardy B, Bedford MT, Mumenthaler SM, Lenz HJ, Kim YM, Wang GG, Pearce KH, James LI, Kireev DB, Musselman CA, Frye SV, Bell O. Reprogramming CBX8-PRC1 function with a positive allosteric modulator. Cell Chem Biol. 2021 Oct 26; doi: 10.1016/j.chembiol.2021.10.003. Epub 2021 Oct 26. PMID: 34715055.
Copy Download .nbib Format: NLM
Expenditures among young adults with acute lymphoblastic leukemia by site of care.

Cancer

Wolfson JA, Bhatia S, Ginsberg J, Becker LK, Bernstein D, Henk HJ, Lyman GH, Nathan PC, Puccetti D, Wilkes JJ, Winestone LE, Kenzik KM.
PMID: 33465248
Cancer. 2021 Jun 01;127(11):1901-1911. doi: 10.1002/cncr.33413. Epub 2021 Jan 19.

BACKGROUND: Individuals diagnosed with acute lymphoblastic leukemia (ALL) between the ages of 22 and 39 years experience worse outcomes than those diagnosed when they are 21 years old or younger. Treatment at National Cancer Institute-designated Comprehensive Cancer Centers (CCC)...

Cite
Wolfson JA, Bhatia S, Ginsberg J, et al. Expenditures among young adults with acute lymphoblastic leukemia by site of care. Cancer. 2021;127(11):1901-1911doi: 10.1002/cncr.33413.
Wolfson, J. A., Bhatia, S., Ginsberg, J., Becker, L. K., Bernstein, D., Henk, H. J., Lyman, G. H., Nathan, P. C., Puccetti, D., Wilkes, J. J., Winestone, L. E., & Kenzik, K. M. (2021). Expenditures among young adults with acute lymphoblastic leukemia by site of care. Cancer, 127(11), 1901-1911. https://doi.org/10.1002/cncr.33413
Wolfson, Julie A, et al. "Expenditures among young adults with acute lymphoblastic leukemia by site of care." Cancer vol. 127,11 (2021): 1901-1911. doi: https://doi.org/10.1002/cncr.33413
Wolfson JA, Bhatia S, Ginsberg J, Becker LK, Bernstein D, Henk HJ, Lyman GH, Nathan PC, Puccetti D, Wilkes JJ, Winestone LE, Kenzik KM. Expenditures among young adults with acute lymphoblastic leukemia by site of care. Cancer. 2021 Jun 01;127(11):1901-1911. doi: 10.1002/cncr.33413. Epub 2021 Jan 19. PMID: 33465248.
Copy Download .nbib Format: NLM
Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Falcone M, Luo C, Chen Y, Birtwell D, Cheatle M, Duan R, Gabriel PE, He L, Ko EM, Lenz HJ, Mirkovic N, Mowery DL, Ochroch EA, Paulson EC, Schriver E, Schnoll RA, Bekelman JE, Lerman C.
PMID: 32859580
Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2126-2133. doi: 10.1158/1055-9965.EPI-20-0628. Epub 2020 Aug 28.

BACKGROUND: The opioid crisis has reached epidemic proportions, yet risk of persistent opioid use following curative intent surgery for cancer and factors influencing this risk are not well understood.METHODS: We used electronic health record data from 3,901 adult patients...

Cite
Falcone M, Luo C, Chen Y, et al. Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer. Cancer Epidemiol Biomarkers Prev. 2020;29(11):2126-2133doi: 10.1158/1055-9965.EPI-20-0628.
Falcone, M., Luo, C., Chen, Y., Birtwell, D., Cheatle, M., Duan, R., Gabriel, P. E., He, L., Ko, E. M., Lenz, H. J., Mirkovic, N., Mowery, D. L., Ochroch, E. A., Paulson, E. C., Schriver, E., Schnoll, R. A., Bekelman, J. E., & Lerman, C. (2020). Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 29(11), 2126-2133. https://doi.org/10.1158/1055-9965.EPI-20-0628
Falcone, Mary, et al. "Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 29,11 (2020): 2126-2133. doi: https://doi.org/10.1158/1055-9965.EPI-20-0628
Falcone M, Luo C, Chen Y, Birtwell D, Cheatle M, Duan R, Gabriel PE, He L, Ko EM, Lenz HJ, Mirkovic N, Mowery DL, Ochroch EA, Paulson EC, Schriver E, Schnoll RA, Bekelman JE, Lerman C. Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer. Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2126-2133. doi: 10.1158/1055-9965.EPI-20-0628. Epub 2020 Aug 28. PMID: 32859580; PMCID: PMC8074574.
Copy Download .nbib Format: NLM
Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients.

Cancer genomics & proteomics

Suenaga M, Zhang WU, Mashima T, Schirripa M, Cao S, Okazaki S, Berger MD, Miyamoto Y, Barzi A, Yamaguchi T, Lenz HJ.
PMID: 33893084
Cancer Genomics Proteomics. 2021 May-Jun;18(3):317-324. doi: 10.21873/cgp.20262.

BACKGROUND: Genetic variants in the CCL5/CCR5 pathway have been shown to predict regorafenib efficacy in patients with metastatic colorectal cancer (mCRC). This study investigated the biological role of CCL4 and CCL3 gene polymorphisms in patients with refractory mCRC treated...

Cite
Suenaga M, Zhang WU, Mashima T, et al. Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients. Cancer Genomics Proteomics. 2021;18(3):317-324doi: 10.21873/cgp.20262.
Suenaga, M., Zhang, W. U., Mashima, T., Schirripa, M., Cao, S., Okazaki, S., Berger, M. D., Miyamoto, Y., Barzi, A., Yamaguchi, T., & Lenz, H. J. (2021). Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients. Cancer genomics & proteomics, 18(3), 317-324. https://doi.org/10.21873/cgp.20262
Suenaga, Mitsukuni, et al. "Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients." Cancer genomics & proteomics vol. 18,3 (2021): 317-324. doi: https://doi.org/10.21873/cgp.20262
Suenaga M, Zhang WU, Mashima T, Schirripa M, Cao S, Okazaki S, Berger MD, Miyamoto Y, Barzi A, Yamaguchi T, Lenz HJ. Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients. Cancer Genomics Proteomics. 2021 May-Jun;18(3):317-324. doi: 10.21873/cgp.20262. PMID: 33893084; PMCID: PMC8126324.
Copy Download .nbib Format: NLM
The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study.

Endoscopy

Taveira F, Hassan C, Kaminski MF, Ponchon T, Benamouzig R, Bugajski M, de Castelbajac F, Cesaro P, Chergui H, Goran L, Minelli Grazioli L, Janičko M, Januszewicz W, Lamonaca L, Lenz J, Negreanu L, Repici A, Spada C, Spadaccini M, State M, Szlak J, Veseliny E, Dinis-Ribeiro M, Areia M.
PMID: 33285583
Endoscopy. 2020 Dec 07; doi: 10.1055/a-1331-4325. Epub 2020 Dec 07.

BACKGROUND: To date, no scale has been validated to assess bubbles associated with bowel preparation. This study aimed to develop and assess the reliability of a novel scale - the Colon Endoscopic Bubble Scale (CEBuS).METHODS: This was a multicenter,...

Cite
Taveira F, Hassan C, Kaminski MF, et al. The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study. Endoscopy. 2020;doi: 10.1055/a-1331-4325.
Taveira, F., Hassan, C., Kaminski, M. F., Ponchon, T., Benamouzig, R., Bugajski, M., de Castelbajac, F., Cesaro, P., Chergui, H., Goran, L., Minelli Grazioli, L., Janičko, M., Januszewicz, W., Lamonaca, L., Lenz, J., Negreanu, L., Repici, A., Spada, C., Spadaccini, M., State, M., Szlak, J., Veseliny, E., Dinis-Ribeiro, M., & Areia, M. (2020). The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study. Endoscopy, . https://doi.org/10.1055/a-1331-4325
Taveira, Filipe, et al. "The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study." Endoscopy vol. (2020). doi: https://doi.org/10.1055/a-1331-4325
Taveira F, Hassan C, Kaminski MF, Ponchon T, Benamouzig R, Bugajski M, de Castelbajac F, Cesaro P, Chergui H, Goran L, Minelli Grazioli L, Janičko M, Januszewicz W, Lamonaca L, Lenz J, Negreanu L, Repici A, Spada C, Spadaccini M, State M, Szlak J, Veseliny E, Dinis-Ribeiro M, Areia M. The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study. Endoscopy. 2020 Dec 07; doi: 10.1055/a-1331-4325. Epub 2020 Dec 07. PMID: 33285583.
Copy Download .nbib Format: NLM
Microsatellite Stable Colorectal Liver Metastases-Understanding the Mechanisms of Immune Resistance.

JAMA network open

Gholami S, Grothey A, Lenz HJ.
PMID: 34369996
JAMA Netw Open. 2021 Aug 02;4(8):e2119025. doi: 10.1001/jamanetworkopen.2021.19025.

No abstract available.

Cite
Gholami S, Grothey A, Lenz HJ. Microsatellite Stable Colorectal Liver Metastases-Understanding the Mechanisms of Immune Resistance. JAMA Netw Open. 2021;4(8):e2119025doi: 10.1001/jamanetworkopen.2021.19025.
Gholami, S., Grothey, A., & Lenz, H. J. (2021). Microsatellite Stable Colorectal Liver Metastases-Understanding the Mechanisms of Immune Resistance. JAMA network open, 4(8), e2119025. https://doi.org/10.1001/jamanetworkopen.2021.19025
Gholami, Sepideh, et al. "Microsatellite Stable Colorectal Liver Metastases-Understanding the Mechanisms of Immune Resistance." JAMA network open vol. 4,8 (2021): e2119025. doi: https://doi.org/10.1001/jamanetworkopen.2021.19025
Gholami S, Grothey A, Lenz HJ. Microsatellite Stable Colorectal Liver Metastases-Understanding the Mechanisms of Immune Resistance. JAMA Netw Open. 2021 Aug 02;4(8):e2119025. doi: 10.1001/jamanetworkopen.2021.19025. PMID: 34369996.
Copy Download .nbib Format: NLM
Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance).

Clinical cancer research : an official journal of the American Association for Cancer Research

Innocenti F, Sibley AB, Patil SA, Etheridge AS, Jiang C, Ou FS, Howell SD, Plummer SJ, Casey G, Bertagnolli MM, McLeod HL, Auman JT, Blanke CD, Furukawa Y, Venook AP, Kubo M, Lenz HJ, Parker JS, Ratain MJ, Owzar K.
PMID: 32958699
Clin Cancer Res. 2021 Jan 01;27(1):267-275. doi: 10.1158/1078-0432.CCR-20-2021. Epub 2020 Sep 21.

PURPOSE: Irinotecan/5-fluorouracil (5-FU; FOLFIRI) or oxaliplatin/5-FU (FOLFOX), combined with bevacizumab or cetuximab, are approved, first-line treatments for metastatic colorectal cancer (mCRC). We aimed at identifying germline variants associated with survival in patients with mCRC treated with these regimens in...

Cite
Innocenti F, Sibley AB, Patil SA, et al. Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 2020;27(1):267-275doi: 10.1158/1078-0432.CCR-20-2021.
Innocenti, F., Sibley, A. B., Patil, S. A., Etheridge, A. S., Jiang, C., Ou, F. S., Howell, S. D., Plummer, S. J., Casey, G., Bertagnolli, M. M., McLeod, H. L., Auman, J. T., Blanke, C. D., Furukawa, Y., Venook, A. P., Kubo, M., Lenz, H. J., Parker, J. S., Ratain, M. J., & Owzar, K. (2021). Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance). Clinical cancer research : an official journal of the American Association for Cancer Research, 27(1), 267-275. https://doi.org/10.1158/1078-0432.CCR-20-2021
Innocenti, Federico, et al. "Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,1 (2021): 267-275. doi: https://doi.org/10.1158/1078-0432.CCR-20-2021
Innocenti F, Sibley AB, Patil SA, Etheridge AS, Jiang C, Ou FS, Howell SD, Plummer SJ, Casey G, Bertagnolli MM, McLeod HL, Auman JT, Blanke CD, Furukawa Y, Venook AP, Kubo M, Lenz HJ, Parker JS, Ratain MJ, Owzar K. Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 2021 Jan 01;27(1):267-275. doi: 10.1158/1078-0432.CCR-20-2021. Epub 2020 Sep 21. PMID: 32958699; PMCID: PMC7785628.
Copy Download .nbib Format: NLM
The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study.

Endoscopy

Taveira F, Hassan C, Kaminski MF, Ponchon T, Benamouzig R, Bugajski M, de Castelbajac F, Cesaro P, Chergui H, Goran L, Minelli Grazioli L, Janičko M, Januszewicz W, Lamonaca L, Lenz J, Negreanu L, Repici A, Spada C, Spadaccini M, State M, Szlak J, Veseliny E, Dinis-Ribeiro M, Areia M.
PMID: 33285583
Endoscopy. 2022 Jan;54(1):45-51. doi: 10.1055/a-1331-4325. Epub 2020 Dec 07.

BACKGROUND: To date, no scale has been validated to assess bubbles associated with bowel preparation. This study aimed to develop and assess the reliability of a novel scale - the Colon Endoscopic Bubble Scale (CEBuS).METHODS: This was a multicenter,...

Cite
Taveira F, Hassan C, Kaminski MF, et al. The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study. Endoscopy. 2020;54(1):45-51doi: 10.1055/a-1331-4325.
Taveira, F., Hassan, C., Kaminski, M. F., Ponchon, T., Benamouzig, R., Bugajski, M., de Castelbajac, F., Cesaro, P., Chergui, H., Goran, L., Minelli Grazioli, L., Janičko, M., Januszewicz, W., Lamonaca, L., Lenz, J., Negreanu, L., Repici, A., Spada, C., Spadaccini, M., State, M., Szlak, J., Veseliny, E., Dinis-Ribeiro, M., & Areia, M. (2022). The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study. Endoscopy, 54(1), 45-51. https://doi.org/10.1055/a-1331-4325
Taveira, Filipe, et al. "The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study." Endoscopy vol. 54,1 (2022): 45-51. doi: https://doi.org/10.1055/a-1331-4325
Taveira F, Hassan C, Kaminski MF, Ponchon T, Benamouzig R, Bugajski M, de Castelbajac F, Cesaro P, Chergui H, Goran L, Minelli Grazioli L, Janičko M, Januszewicz W, Lamonaca L, Lenz J, Negreanu L, Repici A, Spada C, Spadaccini M, State M, Szlak J, Veseliny E, Dinis-Ribeiro M, Areia M. The Colon Endoscopic Bubble Scale (CEBuS): a two-phase evaluation study. Endoscopy. 2022 Jan;54(1):45-51. doi: 10.1055/a-1331-4325. Epub 2020 Dec 07. PMID: 33285583.
Copy Download .nbib Format: NLM
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.

JNCI cancer spectrum

Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA.
PMID: 33426464
JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb.

BACKGROUND: Energy balance-related biomarkers are associated with risk and prognosis of various malignancies. Their relationship to survival in metastatic colorectal cancer (mCRC) requires further study.METHODS: Baseline plasma insulin-like growth factor (IGF)-1, IGF-binding protein (IGFBP)-3, IGFBP-7, C-peptide, and adiponectin were...

Cite
Guercio BJ, Zhang S, Ou FS, et al. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020;5(1):pkaa074doi: 10.1093/jncics/pkaa074.
Guercio, B. J., Zhang, S., Ou, F. S., Venook, A. P., Niedzwiecki, D., Lenz, H. J., Innocenti, F., Pollak, M. N., Nixon, A. B., Mullen, B. C., O'Neil, B. H., Shaw, J. E., Polite, B. N., Benson, A. B., Atkins, J. N., Goldberg, R. M., Brown, J. C., O'Reilly, E. M., Mayer, R. J., Blanke, C. D., Fuchs, C. S., & Meyerhardt, J. A. (2021). IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI cancer spectrum, 5(1), pkaa074. https://doi.org/10.1093/jncics/pkaa074
Guercio, Brendan J, et al. "IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405." JNCI cancer spectrum vol. 5,1 (2021): pkaa074. doi: https://doi.org/10.1093/jncics/pkaa074
Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb. PMID: 33426464; PMCID: PMC7785047.
Copy Download .nbib Format: NLM
Modeling ischemic stroke in a triculture neurovascular unit on-a-chip.

Fluids and barriers of the CNS

Wevers NR, Nair AL, Fowke TM, Pontier M, Kasi DG, Spijkers XM, Hallard C, Rabussier G, van Vught R, Vulto P, de Vries HE, Lanz HL.
PMID: 34906183
Fluids Barriers CNS. 2021 Dec 14;18(1):59. doi: 10.1186/s12987-021-00294-9.

BACKGROUND: In ischemic stroke, the function of the cerebral vasculature is impaired. This vascular structure is formed by the so-called neurovascular unit (NVU). A better understanding of the mechanisms involved in NVU dysfunction and recovery may lead to new...

Cite
Wevers NR, Nair AL, Fowke TM, et al. Modeling ischemic stroke in a triculture neurovascular unit on-a-chip. Fluids Barriers CNS. 2021;18(1):59doi: 10.1186/s12987-021-00294-9.
Wevers, N. R., Nair, A. L., Fowke, T. M., Pontier, M., Kasi, D. G., Spijkers, X. M., Hallard, C., Rabussier, G., van Vught, R., Vulto, P., de Vries, H. E., & Lanz, H. L. (2021). Modeling ischemic stroke in a triculture neurovascular unit on-a-chip. Fluids and barriers of the CNS, 18(1), 59. https://doi.org/10.1186/s12987-021-00294-9
Wevers, Nienke R, et al. "Modeling ischemic stroke in a triculture neurovascular unit on-a-chip." Fluids and barriers of the CNS vol. 18,1 (2021): 59. doi: https://doi.org/10.1186/s12987-021-00294-9
Wevers NR, Nair AL, Fowke TM, Pontier M, Kasi DG, Spijkers XM, Hallard C, Rabussier G, van Vught R, Vulto P, de Vries HE, Lanz HL. Modeling ischemic stroke in a triculture neurovascular unit on-a-chip. Fluids Barriers CNS. 2021 Dec 14;18(1):59. doi: 10.1186/s12987-021-00294-9. PMID: 34906183; PMCID: PMC8670153.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 265 entries